跳至主要内容
临床试验/ITMCTR2100005397
ITMCTR2100005397尚未招募4 期

A randomized, parallel controlled clinical trial of honeysuckle oral liquid in the treatment of children with Hand-foot- and- mouth Disease invading lung and spleen

Enshi Tujia and Miao Autonomous Prefecture Central Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
0 至 18(—)
性别
All

入选标准

  • 1) Over 0.5 years old, regardless of gender;
  • 2) Comply with the diagnostic criteria for hand, foot and mouth disease specified in the guidelines for diagnosis and treatment of hand, foot and mouth disease (2018 Edition) issued by the general office of the National Health Commission; The TCM syndrome differentiation of damp heat and toxin excess syndrome in line with the clinical diagnosis and treatment guide of Pediatrics of traditional Chinese medicine. Hand, foot and mouth disease.
  • 3) The course of disease was 24-48 hours and no other antiviral drugs were used before treatment;
  • 4) Those who voluntarily sign the informed consent form.

排除标准

  • 1) Age < 0.5 years
  • 2) Exclude diseases that need to be distinguished from hand, foot and mouth disease, such as atypical measles, rubella, infant emergency rash, chickenpox / herpes zoster and papular urticaria.
  • 3) Headache and vomiting; Mental retardation, drowsiness, easily startled, delirium and any other manifestations of nervous system involvement;
  • Limb shaking, muscle clonus, nystagmus, ataxia, eye movement disorder;
  • Weakness or acute flaccid paralysis;
  • Symptoms of convulsion and meningeal irritation, weakening or disappearance of tendon reflex, frequent convulsions, coma, hernia, dyspnea, cyanosis, bloody sputum, pulmonary rales, shock and other circulatory dysfunction, etc.
  • 4) Children with severe primary diseases such as heart, cerebrovascular, liver, kidney and hematopoietic system and mental illness;
  • 5) With pharyngeal conjunctivitis, acute obstructive laryngotracheal bronchitis, bronchiolitis, pneumonia, active tuberculosis, bronchiectasis or other basic lung diseases;
  • 6) Those who have used other Chinese and Western drugs for the treatment of the disease within 48 hours (such as glucocorticoid, human gamma globulin, interferon, traditional Chinese medicine, etc.);
  • 7) Those who have known a history of allergy to the components of this drug, and those who have allergies to food and more than 2 drugs;
  • 8) Those who have participated in other clinical trials within 1 month;
  • 9) Other reasons that doctors consider unsuitable for inclusion;
  • 10) The family disagreed

研究者

发起方
Enshi Tujia and Miao Autonomous Prefecture Central Hospital

相似试验

A randomized, parallel controlled clinical trial of... | 临床试验